DMRT1
Basic information
Region (hg38): 9:841690-969090
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DMRT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | |||||
missense | 34 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 4 | ||||
non coding | 21 | 28 | ||||
Total | 0 | 5 | 35 | 16 | 29 |
Variants in DMRT1
This is a list of pathogenic ClinVar variants found in the DMRT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-841825-C-T | Benign (Nov 12, 2018) | |||
9-841866-C-T | Uncertain significance (Aug 23, 2023) | |||
9-841906-C-T | not specified | Uncertain significance (Aug 11, 2024) | ||
9-841914-G-A | not specified | Uncertain significance (Feb 03, 2022) | ||
9-841959-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
9-841970-C-T | not specified | Likely benign (Nov 10, 2024) | ||
9-841971-T-A | Benign (Jan 31, 2024) | |||
9-842011-C-G | not specified | Uncertain significance (Feb 24, 2022) | ||
9-842013-G-C | not specified | Uncertain significance (Nov 14, 2024) | ||
9-842031-G-T | not specified | Uncertain significance (Sep 16, 2021) | ||
9-842032-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
9-842032-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
9-842033-C-G | Likely benign (Jun 23, 2018) | |||
9-842050-C-G | Uncertain significance (Jun 23, 2023) | |||
9-842051-G-A | Benign (Mar 09, 2023) | |||
9-842082-C-T | Uncertain significance (Sep 06, 2023) | |||
9-842146-A-G | Likely benign (Jun 22, 2022) | |||
9-842153-C-G | Likely pathogenic (Jun 01, 2024) | |||
9-842170-G-T | 46,XY sex reversal 4 | Likely pathogenic (Feb 27, 2017) | ||
9-842182-T-A | Non-obstructive azoospermia | Likely pathogenic (Aug 23, 2021) | ||
9-842315-AC-A | Benign (Jun 21, 2021) | |||
9-842395-C-T | Benign (Jun 19, 2021) | |||
9-842568-C-G | Likely benign (Jan 01, 2023) | |||
9-846742-G-C | Benign (Jun 18, 2021) | |||
9-846952-G-C | Benign (Jan 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DMRT1 | protein_coding | protein_coding | ENST00000382276 | 5 | 127401 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.739 | 0.261 | 124932 | 0 | 814 | 125746 | 0.00324 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.438 | 234 | 216 | 1.08 | 0.0000108 | 2416 |
Missense in Polyphen | 59 | 69.432 | 0.84975 | 845 | ||
Synonymous | -3.60 | 134 | 90.4 | 1.48 | 0.00000486 | 749 |
Loss of Function | 2.85 | 2 | 13.2 | 0.152 | 5.69e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00406 | 0.00386 |
Ashkenazi Jewish | 0.00202 | 0.00199 |
East Asian | 0.00266 | 0.00261 |
Finnish | 0.0138 | 0.0131 |
European (Non-Finnish) | 0.00297 | 0.00288 |
Middle Eastern | 0.00266 | 0.00261 |
South Asian | 0.000722 | 0.000719 |
Other | 0.00372 | 0.00359 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor that plays a key role in male sex determination and differentiation by controlling testis development and male germ cell proliferation. Plays a central role in spermatogonia by inhibiting meiosis in undifferentiated spermatogonia and promoting mitosis, leading to spermatogonial development and allowing abundant and continuous production of sperm. Acts both as a transcription repressor and activator: prevents meiosis by restricting retinoic acid (RA)-dependent transcription and repressing STRA8 expression and promotes spermatogonial development by activating spermatogonial differentiation genes, such as SOHLH1. Also plays a key role in postnatal sex maintenance by maintaining testis determination and preventing feminization: represses transcription of female promoting genes such as FOXL2 and activates male-specific genes. May act as a tumor suppressor. May also play a minor role in oogenesis (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Testicular germ cell tumor (TGCT) [MIM:273300]: A common malignancy in males representing 95% of all testicular neoplasms. TGCTs have various pathologic subtypes including: unclassified intratubular germ cell neoplasia, seminoma (including cases with syncytiotrophoblastic cells), spermatocytic seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma. {ECO:0000269|PubMed:20543847}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XY sex reversal 4 (SRXY4) [MIM:154230]: A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. Patients display complete or partial gonadal dysgenesis and a chromosome 9p deletion. {ECO:0000269|PubMed:21048976, ECO:0000269|PubMed:9490411, ECO:0000269|PubMed:9718346}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- loftool
- 0.0628
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.56
Haploinsufficiency Scores
- pHI
- 0.452
- hipred
- Y
- hipred_score
- 0.597
- ghis
- 0.401
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.935
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dmrt1
- Phenotype
- reproductive system phenotype; endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- dmrt1
- Affected structure
- spermatogonium
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;cell morphogenesis;male germ cell proliferation;spermatogenesis;germ cell migration;male sex determination;intracellular signal transduction;negative regulation of meiotic nuclear division;positive regulation of mitotic nuclear division;positive regulation of transcription by RNA polymerase II;male sex differentiation;oocyte development;Sertoli cell differentiation;Sertoli cell development;positive regulation of meiosis I;regulation of nodal signaling pathway;positive regulation of male gonad development
- Cellular component
- nucleus;cytoplasm
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;proximal promoter sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;identical protein binding;protein homodimerization activity;metal ion binding;protein heterodimerization activity